Literature DB >> 17069032

[Metabolic syndrome, obesity and urolithiasis].

Olivier Traxer1, Hélène Safar, Michel Daudon, Jean-Philippe Haymann.   

Abstract

The current concept of metabolic syndrome comprises abdominal obesity and cardiovascular risk factors (HT and metabolic disorders). Compared to a control group, individuals with metabolic syndrome have a fourfold higher risk of cardiovascular disease and an increased risk of diabetes. Apart from cardiovascular morbidity, these patients also appear to have an increased incidence of urolithiasis. Urologists must therefore recognize this syndrome in order to identify this particular subgroup of urolithiasis patients. The objective of this article is to review the metabolic syndrome in order to help urologists to recognize this syndrome so that they can identify patients requiring more specific management and medical follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 17069032

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  4 in total

1.  Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis.

Authors:  Hasan Aydin; Faruk Yencilek; Ismet Bilger Erihan; Binnur Okan; Kemal Sarica
Journal:  Urol Res       Date:  2011-05-13

2.  Systemic endothelial function measured by flow-mediated dilation is impaired in patients with urolithiasis.

Authors:  Esin Yencilek; Hakan Sarı; Faruk Yencilek; Ezgi Yeşil; Hasan Aydın
Journal:  Urolithiasis       Date:  2016-11-23       Impact factor: 3.436

3.  A high basal metabolic rate is an independent predictor of stone recurrence in obese patients.

Authors:  Ho Won Kang; Sung Pil Seo; Hee Youn Lee; Kyeong Kim; Yun Sok Ha; Won Tae Kim; Yong June Kim; Seok Joong Yun; Wun Jae Kim; Sang Cheol Lee
Journal:  Investig Clin Urol       Date:  2021-03

4.  Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis.

Authors:  Hee Youn Lee; Ho Won Kang; Kyeong Kim; Yun-Sok Ha; Won Tae Kim; Yong-June Kim; Seok Joong Yun; Wun-Jae Kim; Sang-Cheol Lee
Journal:  Investig Clin Urol       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.